SP363DESIGN OF A MULTICENTER, NON-INTERVENTIONAL, POST-AUTHORIZATION SAFETY STUDY OF ANEMIC CKD PATIENTS RECEIVING BIOSIMILAR EPOETIN ALFA. (13th June 2019)